← Eichor
Condition: Biliary And Pancreatic Diseases Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Biliary And Pancreatic Diseases

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
NA · 2 location(s) · Anna Evans Phillips · NCT03434392EUS Procedures Using RIVOS™ EUS Access Device
Phase N/A · 1 location(s) · Orlando Health, Inc. · NCT07696572Study for AZD4360 in Participants With Advanced Solid Tumours
Phase 1/Phase 2 · 18 location(s) · AstraZeneca · NCT06921928COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients
Phase 2 · 2 location(s) · Zhejiang University · NCT07012772Influence of Gut Microbiome in Gallstone Disease
Phase N/A · 1 location(s) · East Kent Hospitals University NHS Foundation Trust · NCT05732480The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder Cancer
Phase N/A · 1 location(s) · Samsung Medical Center · NCT03637569Calgary Registry for Advanced and Therapeutic Endoscopy
Phase N/A · 1 location(s) · University of Calgary · NCT04259580This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Tor
Phase 1 · 3 location(s) · Zumutor Biologics Inc. · NCT06451497Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepat
Phase N/A · 1 location(s) · University of Chicago · NCT01416714At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
Phase 2 · 2 location(s) · Mayo Clinic · NCT05969860CDH17 CAR-T Therapy in Advanced Malignant Solid Tumors
EARLY_Phase 1 · 1 location(s) · Zhejiang University · NCT06937567Study Assessing PET Imaging With Zirconium-labelled Girentuximab in Patients With HCC, BTC or NEN
NA · 2 location(s) · Nantes University Hospital · NCT06735560Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · ModeX Therapeutics, An OPKO Health Company · NCT06239194CPI-613 (Devimistat) in Combination With Hydroxychloroquine and 5-fluorouracil or Gemcitabine in Treating Patients With
Phase 2 · 1 location(s) · Northwestern University · NCT05733000Distance-Based Exercise to Preserve Function and Prevent Disability
NA · 18 location(s) · Alliance for Clinical Trials in Oncology · NCT07059884Phase I/II Clinical Study to Evaluate VB15010 Tablets in Patients With Advanced Solid Tumors
Phase 1/Phase 2 · 1 location(s) · Zhejiang Yangli Pharmaceutical Technology Co., Ltd. · NCT06819215A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Antitumor Activity of INV-8989 in Patien
Phase 1/Phase 2 · 1 location(s) · Shenzhen Ionova Life Sciences Co., Ltd. · NCT07610798PET Imaging of Solid Tumors by a Novel Tracer, 68Ga-FAPI
Phase 1 · 1 location(s) · Karolinska University Hospital · NCT05172310Efficacy of Fistulotomy for Biliary Cannulation
NA · 1 location(s) · Coordinación de Investigación en Salud, Mexico · NCT04037007Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors
Phase 1 · 21 location(s) · I-Mab Biopharma US Limited · NCT04900818Tissue Adhesive Glue Modified Cyanoacrylate (Glubran® 2) in Soft Pancreas
Phase 3 · 1 location(s) · Minia University · NCT07155525Single Plastic Stent Vs. Fully Covered Self-Expanding Metal Stent on Benign Biliary Stricture Secondary to Chronic Pancr
NA · 1 location(s) · Changhai Hospital · NCT06655051DESTINY-PANTUMOUR04
Phase N/A · 18 location(s) · AstraZeneca · NCT07124000To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With H
Phase 1 · 2 location(s) · Shenzhen Xinhe Biomedical · NCT07594964A Clinical Trial Targeting CEA Chimeric Antigen Receptor T (CAR-T) for CEA Positive Advanced Malignant Solid Tumors
Phase 1 · 2 location(s) · Chongqing Precision Biotech Co., Ltd · NCT06043466AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Phase 2 · 52 location(s) · AstraZeneca · NCT06219941Ursodeoxycolic Acid for the Prevention of Relapsing Complications After Gallstone Acute Pancreatitis
Phase 3 · 18 location(s) · Hospital General Universitario de Alicante · NCT04924868The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Tr
Phase 2 · 1 location(s) · Mayo Clinic · NCT07285044Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
Phase N/A · 1 location(s) · National Cancer Institute (NCI) · NCT01950572An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis
Phase N/A · 1 location(s) · University of Copenhagen · NCT05335603
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.